Active Ingredient(s): Diroximel Fumarate
FDA Approved: * October 29, 2019
Pharm Company: * BIOGEN
Category: Multiple Sclerosis
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Recent Vumerity Forums:
Be the first to start a discussion
about this drug.
Possible Dosages for this and Related Drugs:
- Capsule, Delayed Release: 120mg, 231mg, 240mg
- Solution: 50%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.
NDC Database Records for Vumerity: (1 result)
Sorted by National Drug Code
- 64406-020 Vumerity 231 mg Oral Capsule by Biogen Inc.
Other drugs which contain Diroximel Fumarate or a similar ingredient: (4 results)